Date: 
Live Webcast: October 22, 2008
Archive: The recorded Webcast is available to watch/listen to until April 22, 2009

Topic:
Adoption of International Financial Reporting Standards (IFRS) in the United States is increasingly a question of when rather than if. What does this development mean for life sciences organizations? We'll discuss:

• The global IFRS landscape, including likely timing of adoption in the United States and why life sciences may be one of the first off the blocks.
• Relevant accounting differences between Generally Accepted Accounting Principles (GAAP) and IFRS, and the impact on areas such as research & development, revenue recognition and impairment.
• The collateral impact of IFRS adoption on the finance transformation initiatives under way at many life sciences companies.

Learn more about what life sciences organizations can be doing now to prepare. 

Host: 
Steve Burrill, partner, Deloitte & Touche LLP

Presenters: 
David Hodgson, partner, Deloitte & Touche LLP
Samuel Silvers, principal, Deloitte Consulting LLP
Mary Kane, finance director, Financial Compliance & Procedures, Johnson & Johnson

Duration: 1 hour

Sign Up:  Register (free; registration required) to watch/listen to the archived Webcast

Related Content: 
Report: IFRS in Life Sciences 
Overview: Life Sciences